Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)

Clinical trial NCT04411654 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04411654
Sponsor: Prevail Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gaucher Disease, Type 2

Start date: 2021-06-29
Primary completion: 2027-02-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.